|
Status |
Public on Aug 18, 2020 |
Title |
Metabolic adaptations underlie epigenetic vulnerabilities in chemoresistant breast cancer |
Organism |
Homo sapiens |
Experiment type |
Expression profiling by high throughput sequencing Genome binding/occupancy profiling by high throughput sequencing Methylation profiling by genome tiling array
|
Summary |
This SuperSeries is composed of the SubSeries listed below.
|
|
|
Overall design |
Refer to individual Series
|
|
|
Citation(s) |
32546577 |
|
Submission date |
Apr 25, 2018 |
Last update date |
Aug 18, 2020 |
Contact name |
Genevieve Deblois |
E-mail(s) |
[email protected]
|
Organization name |
University Health Network, University of Toronto
|
Department |
Medical Biophysics
|
Lab |
Mathieu Lupien
|
Street address |
101 College street
|
City |
Toronto |
State/province |
Ontario |
ZIP/Postal code |
M5G 1L7 |
Country |
Canada |
|
|
Platforms (3) |
GPL11154 |
Illumina HiSeq 2000 (Homo sapiens) |
GPL18573 |
Illumina NextSeq 500 (Homo sapiens) |
GPL21145 |
Infinium MethylationEPIC |
|
Samples (114)
|
|
This SuperSeries is composed of the following SubSeries:
|
GSE111541 |
Metabolic adaptations underlie epigenetic vulnerabilities in chemoresistant breast cancer [Methylation profiling] |
GSE111920 |
Metabolic adaptations underlie epigenetic vulnerabilities in chemoresistant breast cancer. [RNA-Seq1] |
GSE113684 |
Metabolic adaptations underlie epigenetic vulnerabilities in chemoresistant breast cancer. [ChIP-Seq] |
GSE113685 |
Metabolic adaptations underlie epigenetic vulnerabilities in chemoresistant breast cancer. [RNA-Seq2] |
|
Relations |
BioProject |
PRJNA453605 |